Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 3Completed 1

Sponsor Class

INDUSTRY 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gynecologic 3

Conditions

Uterine Cervical Dysplasia 3Papillomavirus Infections 1

Interventions

Imiquimod 4Vaccines 3GX-188 vaccine 3Papanicolaou Test 2Colposcopy 2poly ICLC 1nimotuzumab 1efineptakin alfa 1Vaginal Smears 1Transcription Activator-Like Effector Nucleases 1TachoSil 1Surveys and Questionnaires 1Papillomavirus Vaccines 1Ocoxin 1Mindfulness 1Laser Therapy 1Interviews as Topic 1High-Intensity Focused Ultrasound Ablation 1HIV Testing 1GPI0100 1Exercise 1Cryotherapy 1Cisplatin 1CRISPR-Associated Protein 9 1Brachytherapy 1Antigens 1Adjuvants, Pharmaceutic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Uterine Cervical Dysplasia × GX-188 vaccine × Clear all
NCT02100085 2017-07-12

Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation

Genexine, Inc.

Unknown
9 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT02411019 2017-07-12

GX-188E

Genexine, Inc.

Unknown
67 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT02596243 2017-07-12

Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)

Genexine, Inc.

Phase 2 Unknown
134 enrolled
Gynecologic

Uterine Cervical Dysplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡